According to the latest research conducted by the global company Synthetic Camphor Pharma Market The volume is expected to reach US$532.0 million by the end of 2028.
The report on the pharma grade Synthetic Camphor market anticipates significant growth potential with a proven average annual growth rate of 4.1% till 2028.
The increasing demand for topical pain management products is expected to drive the growth of the pharmaceutical grade synthetic camphor market. Pharma grade synthetic camphor is used in many topical analgesic products such as oils, ointments, breast scrubs and gels.
Pharmaceutical grade synthetic camphor pain management products are experiencing significant growth due to fewer side effects compared to oral analgesics and expanded access to retail channels. Increasing the rate of self-medication and availability of cost-effective camphor containing OTC analgesic is fueling the growth of the pharmaceutical grade synthetic camphor market.
The rising incidence of infectious diseases like cold and flu has led to the increased use of cold sore remedies, nasal decongestants, topical repellents etc., which in turn will lead to the growth of the pharmaceutical grade synthetic camphor market. The increased use of privately labeled camphor-containing topical products is increasing the demand for pharmaceutical grade synthetic camphor.
Private label analgesics are gaining popularity in the US market because they do not require FDA approval and aggressive promotional activities by retailers. Walgreens Ultra Strength Muscle Rub (4% camphor), Salonpas Pain Relief Patch (1.2% camphor) are examples of specialty camphor-containing pain relievers. The significant increase in commodity export, economic growth and production capacity is expected to boost the growth of the pharmaceutical grade synthetic camphor market.
However, the regulatory restrictions on the use of camphor in pharmaceutical products drugs would greatly affect the growth of the pharmaceutical grade synthetic camphor market. Moreover, the increase in raw material prices is expected to hamper the growth of the synthetic camphor market used in the pharmaceutical industry. Thus, high prices of raw materials, such as alpha-pinene oil or turpentine oil, are a major challenge for manufacturers of pharmaceutical grade synthetic camphor.
The company has segmented the global pharmaceutical grade synthetic camphor market into formulations, application, distribution, and regions. Based on the composition, the pharma grade synthetic camphor market is segmented into topical and inhaled. The topical segment is expected to account for the highest revenue share in the pharmaceutical grade synthetic camphor market owing to the high number of products marketed and broad applications. The applications of pharmaceutical grade synthetic camphor included in the report are those of respiratory disorders, muscular rheumatism, anti-irritant and antipruritic and others (topical analgesic, cold sores, minor burns, antifungal, hemorrhoids, topical antitussive and expectorant, astringent, expectorant, etc.). ) . The other segment is expected to contribute the highest market value in the global pharmaceutical grade synthetic camphor market. Based on distribution channel, the pharma grade synthetic camphor market is segmented into traditional B2B channel and online B2B channel. In terms of revenue, the traditional B2B segment will command a significant revenue share in the pharmaceutical grade synthetic camphor market during the forecast period.
On the basis of region, the global pharmaceutical grade synthetic camphor market has been segmented into North America, Latin America, Western Europe, Eastern Europe, and Asia Pacific excluding China, Japan, China, Japan, the Middle East and Africa. North America is expected to contribute the highest revenue share to the global pharmaceutical grade synthetic camphor market. The demand for synthetic, pharmaceutical-grade camphor has increased in North America, as camphor production has contained both private label and over-the-counter products. China is expected to witness the highest growth rate in the pharmaceutical grade synthetic camphor market due to the presence of more number of pharmaceutical grade synthetic camphor manufacturers. Manufacturers of pharma grade synthetic camphor are concentrated in China and India and export their chemicals to the United States and Europe. Moreover, due to its increasing contribution to the global industry, the Asia Pacific region is emerging as a focused destination for global manufacturers of camphor and related chemicals.
Request the full table of contents for this report @ https://www.futuremarketinsights.com/toc/rep-gb-7564
2016-2021 Pharma Synthetic Camphor Demand Forecast Compared To Forecast 2022-2028
The global pharmaceutical grade synthetic camphor market has witnessed transformation growth from 2016 onwards and this trend is expected to continue during the forecast period, which will drive up the demand for pharmaceutical grade synthetic camphor. In addition, the incidence of many infectious diseases is increasing globally. Indicators such as respiratory and sexually transmitted diseases are increasing at an alarming rate in countries all over the world.
Populated areas such as APAC, MEA and Latin America have a high incidence and prevalence of infectious diseases, which in turn increases the demand for camphor-containing treatment products for infectious diseases. Also, the increase in the use of private label topical products containing camphor, which was driven by positive consumer sentiment and the increasing demand for topical pain management products are the other factors driving the growth of the pharmaceutical grade synthetic camphor market.
The global pharmaceutical grade synthetic camphor market will constitute approximately 4.4% of the USD 9 billion pharmaceutical excipients market globally in 2021. The private-branded industry is experiencing explosive growth in the US market, driven by positive consumer sentiment towards these products.
Hence, the demand forecast for the pharmaceutical grade synthetic camphor market is expected to grow rapidly during the forecast period from 2022 to 2028. The pharmaceutical grade synthetic camphor market is expected to expand at a significant growth rate of around 4.2% as a compound annual growth rate (CAGR) and a gradual growth is observed An opportunity of $116.6 million from 2022 to 2028.
The report tracks some of the key companies operating in the global Pharmaceutical-grade Synthetic Camphor market. The representative players listed in the global Pharmaceutical Grade Synthetic Camphor market report are Merck KGaA, Oriental Aromatics Limited, Saptagir Camphor Limited, Mangalam Organics Limited, Nippon Fine Chemical Co., Ltd. and Rochem International, Inc. and Spectrum Chemical Mfg. Corp. , Aldon Corporation, Prinova Group LLC. and Fengchen Group Co., Ltd. Manufactures focus on improving the supply chain which is expected to provide tremendous opportunities for them during the forecast period.
Pharma Grade Synthetic Camphor Market Segmentation – By Category
By type of formula:
- Respiratory disorders
- muscular rheumatism
- Anti-irritation and anti-itch
by Distribution channels:
- traditional B2B
- direct purchase
- Wholesalers and distributors
- B2B online
- inner channel
- external channel
- North America
- Latin america
- Western Europe
- Eastern Europe
- your father
- Middle East and Africa